Beruflich Dokumente
Kultur Dokumente
HIGHLIGHTS
• There were 20,778 samples tested for COVID-19 within the last 24 hours.
• Eight-hundred-four (804) COVID-19 cases are detected among the tested people bringing the total
confirmed cases to 55,213.
• Three-hundred-eighty (380) cases recovered today which brings the total COVID-19 recovered cases to
20,699 in the country.
• Ten• (10) new COVID-19 related deaths occurred today bringing the total number of COVID-19 deaths to
856.
• A total of 14, 819 contacts of confirmed cases have been tested positive so far.
970,591 55,213
TOTAL LABORATORY TESTS TOTAL 20,699 856
CONFIRMED CASE TOTAL RECOVERED TOTAL DEATH
DONE
COVID-19 GLOBAL UPDATE
Access link for WHO COVID-19 monitoring dashboard: https://covid19.who.int/
BACKGROUND
Ethiopia activated its IMS under the national PHEOC. The WHO and other partners are currently supporting in
scaling up preparedness efforts and implementation of related recommendations suggested by the IHR Emergency
Committee. Different layer so coordination platform revitalized and the PHEOC is working collaboratively with
various agency representative, Partners, Embassies, hospitality sector, Industrial parks and others. There is strong
communication and updating from other countries through IHR-NFPs. The sub-national level is well engaged in the
preparedness and response efforts. Joint regular media briefing sessions are being conducted. The first confirmed case
of COVID-19 was detected on 13th March 2020, this was a day after WHO declared COVID-19 as a pandemic.
Table 1: Summary of laboratory tests, new cases and deaths nationally as of September 03, 2020
Regions/City Admin # Tests conducted # of New Cases Test positivity rate # of New deaths
Tigray 800 134 17% 0
Oromia 3357 141 4% 0
Sidama 377 52 14% 0
SNNPRS 2802 86 3% 1 (from HF)
Benshangul Gumuz 449 1 0% 0
Afar 187 11 6% 0
Gambella 502 6 1% 0
Amhara 7176 50 1% 2 (from HF)
Dire Dawa 438 10 2% 1 (from HF)
Harari 594 28 5% 0
Addis Ababa 3652 258 7% 6 (from HF)
Somali 444 27 6% 0
Total 20778 804 4% 10 (all from HF)
Fig. 3: Summary of COVID-19 situation in Ethiopia as of September 03, 2020
Fig. 4: Trend of COVID-19 confirmed cases, death and recovery by date of reporting till September 03, 2020.
Laboratory test:
• 20,778 laboratory samples were tested for COVID-19 in the last 24 hours; 804 (3.87%) positives and 19,974
(96.13%) negatives were detected.
• As of September 03, 2020, a total of 970,591 samples has been tested for COVID-19 by laboratories in the country.
Fig. 5: Summary of Laboratory testing related activity as of September 03, 2020.
Fig. 6: Summary of COVID-19 cases contact tracing update in Ethiopia as of September 03, 2020
Rumors collection and verification from all sources
• As of September 03, 2020:
o 215,440 rumors/alerts have been received and investigated. Of these, 9,597 rumors are reported today.
o 165,406 (76.78%) of the rumors/alerts have fulfilled the suspected case definition. Of these, 8,557 are
reported today.
• On September 03, 2020, a total of 11,685 calls were received and responded via toll-free call centers. Of these, 9,866
(84.43%) of the calls were COVID-19 related calls and 58 rumors were received.
Source Link
WHO Coronavirus (COVID-19) dashboard https://covid19.who.int/
Africa CDC Dashboard, COVID-19 Surveillance https://au.int/en/covid19
Dashboard
WHO COVID-19 daily situation reports https://www.who.int/emergencies/diseases/novel-coronavirus-
2019/situation-reports
WHO Academy mobile learning app for health https://play.google.com/store/apps/details?id=org.who.WHOA
Ongoing and completed COVID-19 studies listed https://clinicaltrials.gov/ct2/who_table
on the World Health Organization's International
Clinical Trials Registry Platform (WHO ICTRP)
Prevalence of phenotypes of acute • In this exploratory analysis of 39 patients, ARDS due to COVID-19 was not
respiratory distress syndrome in associated with higher systemic inflammation and was associated with a
critically ill patients with COVID- lower prevalence of the hyperinflammatory phenotype than that observed in
19: a prospective observational historical ARDS data. This finding suggests that the excess mortality
study observed in COVID-19-related ARDS is unlikely to be due to the
https://doi.org/10.1016/S2213- upregulation of inflammatory pathways described by the parsimonious
2600(20)30366-0 model.
Infectivity of Human Olfactory • Our findings strengthen the reported association of SARS-CoV-2 infection
Neurons to SARS-CoV-2: A Link with loss of smell in individuals infected with the virus. Our results suggest
to Anosmia that olfactory neurons, originating from both genders, were highly permissive
https://ssrn.com/abstract=366836 to SARS-CoV-2 infection. Moreover, there were no differences in
9 permissiveness to infection between male and female neurons. The infrequent
susceptibility of other undifferentiated or partially differentiated neurons
suggest it would be unlikely that SARS-CoV-2 infects other mature human
brain neurons since, after birth, they have mostly completed neurogenesis.
Our studies confirm the neurotropism of the SARS-CoV-2 to olfactory
neurons. Preliminary observations indicate that viral entry is mediated by the
TMPRSS2 receptor.
Guide Link
Considerations for quarantine of https://www.who.int/publications/i/item/considerations-for-quarantine-of-
individuals in the context of individuals-in-the-context-of-containment-for-coronavirus-disease-(covid-19)
containment for coronavirus
disease (COVID-19)
Home care for patients with https://www.who.int/publications/i/item/home-care-for-patients-with-suspected-
suspected or confirmed novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-
COVID-19 and management of management-of-contacts
their contacts
Global COVID-19 Clinical https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical_CRF-2020.4
Platform: Rapid core case report
form (CRF)
Global COVID-19 Clinical https://www.who.int/publications/i/item/WHO-2019-nCoV-Pregnancy_CRF-
Platform: Pregnancy Case 2020.5
Report Form (CRF)
Interim Considerations for https://www.cdc.gov/coronavirus/2019-ncov/community/homeless-
Health Departments for SARS- shelters/testing.html
CoV-2 Testing in Homeless
Shelters and Encampments
WHO COVID-19 Preparedness https://www.who.int/publications/m/item/who-covid-19-preparedness-and-
and Response Progress Report – response-progress-report---1-february-to-30-june-2020
1 February to 30 June 2020
Reagent calculator for portal https://www.who.int/publications/m/item/reagent-calculator-for-portal
Call-Centers
FOR MORE INFO and
ALERT NOTIFICATION on
COVID-19
The above presented Quick Reader (QR) code takes you to a portal that you can access updates and all COVID-19 related information available
(https://www.ephi.gov.et/index.php/public-health-emergency/novel-corona-virus-update)
DISCLAIMER
Figures presented in this situation report are pulled from official releases of the World Health Organization,
Other sources from the web, as well as report compiled by the National Incidence Response Team
PREPARED BY
Fantu Lombamo (MD, MPH) – Planning Section, Situation Unit Lead
Negusse Yohannis (PhD in Statistics) – Planning Section, Situation Unit Member
CONTRIBUTORS
Zelalem Kebede (MPH) - Planning Section, Situation Unit Member